The Drug Discovery Informatics Market Report 2021-2031: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Applying High-Performance Computing in Drug Discovery and Molecular Simulation
High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government. This technique has resulted in a number of novel drug design algorithms and new software and databases. HPC is primarily applied to the discovery and molecular modelling of medication by the Chinese Academy of Sciences, including virtual drug screening, molecular simulation dynamics and protein folding.
Growth in Demand for Novel Drug Moieties
The therapeutic moieties cannot as such be administered, hence, for patient compliance, dose precision and consistency, bioavailability, aesthetics, and reduced adverse effects, they are changed to different dosage forms. Excipients are the basic needs for these changes, so that formulators can achieve their goals. Short excipients can be described as ‘the components of a formula other than the active component.’ As compounds grow increasingly difficult to create, the supply, production and development of these compounds must be supplied with novel excipients. The conventional excipients have been replaced with advanced chemicals that serve multifunctional roles in current pharmaceutical dosage forms such as improved stability and bioavailability, patient acceptance and technical performance to make manufacturing easier.
What Are These Questions You Should Ask Before Buying A Market Research Report?
• How is the drug discovery informatics market evolving?
• What is driving and restraining the drug discovery informatics market?
• How will each drug discovery informatics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2031?
• How will the market shares for each drug discovery informatics submarket develop from 2021 to 2031?
• What will be the main driver for the overall market from 2021 to 2031?
• Will leading drug discovery informatics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2031 and which geographical region will lead the market in 2031?
• Who are the leading players and what are their prospects over the forecast period?
• What are the drug discovery informatics projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2031?What are the implication of drug discovery informatics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the drug discovery informatics market?
• Where is the drug discovery informatics market heading? And how can you ensure you are at the forefront of the market?
• What can be the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path? C-suite?
You need to discover how this will impact the drug discovery informatics market today, and over the next 10 years:
• Our 519-page report provides 341 tables and 323 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• Contains in-depth analyse of global, regional and national sales and growth
• Highlights for you the key successful trends, changes and revenue projections made by your competitors
This report tells you TODAY how the drug discovery informatics market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Delivers exclusive COVID-19 variations economic data specific to your market.
To access the data contained in this document please email contactus@visiongain.com
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising drug discovery informatics prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.
Global Drug Discovery Informatics Market (COVID Impact Analysis) by Type
• Drug Development
• Drug Discovery
Global Drug Discovery Informatics Market (COVID Impact Analysis) by Phase
• Preclinical Testing
• Clinical Trials Phase
• Other Phase
Global Drug Discovery Informatics Market (COVID Impact Analysis) by End-User
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations
• Research Institutes
• Other End-User
Global Drug Discovery Informatics Market (COVID Impact Analysis) by Function
• Target Data
• Sequencing & Target Data Analysis
• Docking
• Molecular Modeling
• High Throughput Screening (HTS)
• Other Function
Global Drug Discovery Informatics Market (COVID Impact Analysis) by Technique
• Computer-Assisted Synthesis Design (CASD)
• Structure Representation
• Chemmetrics
• Other Technique
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 15 leading national markets:
• North America Drug Discovery Informatics Market, 2021 to 2031 Market Outlook
• U.S. Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Canada Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Mexico Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Europe Drug Discovery Informatics Market, 2021 to 2031 Market Outlook
• Germany Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Spain Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• United Kingdom Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• France Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Italy Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Rest of Europe Market Forecast & COVID Impact Analysis
• Asia Pacific Drug Discovery Informatics Market, 2021 to 2031 Market Outlook
• China Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Japan Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• India Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Australia Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• South Korea Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Rest of Asia Pacific Market Forecast & COVID Impact Analysis
• LAMEA Drug Discovery Informatics Market, 2021 to 2031 Market Outlook
• Brazil Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Turkey Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Saudi Arabia Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• South Africa Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• UAE Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Rest of Latin America, Middle East and Africa
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Drug Discovery Informatics Market, 2021 to 2031, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Jubilant Life Sciences
• Charles River Laboratories International
• International Business Machines Corporation
• Clarivate Analytics
• Accenture
• Cognizant Technology Solutions Corporation
• Thermo Fisher Scientific
• Infosys Limited
• GVK Biosciences
• IO Informatics
• OpenEye Scientific Software Inc.
• Dassault Systèmes SE
• Collaborative Drug Discovery
• Schrödinger, Inc
• PerkinElmer Inc
Overall world revenue for Drug Discovery Informatics Market, 2021 to 2031 in terms of value the market will surpass US$xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Drug Discovery Informatics Market, 2021 to 2031 Market report helps you?
In summary, our 519-page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Drug Discovery Informatics Market, 2021 to 2031 Market, with forecasts for type, phase, function, end-user, technique each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 4 regional and 20 key national markets – See forecasts for the Drug Discovery Informatics Market, 2021 to 2031 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 15 of the major companies involved in the Drug Discovery Informatics Market, 2021 to 2031 Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Drug Discovery Informatics Market, 2021 to 2031 Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Drug Discovery Informatics Market Report 2021-2031: Forecasts by Type (Drug Development, Drug Discovery), by Phase (Preclinical Testing, Clinical Trials, Other), by End-user (Pharmaceutical, Biotechnology, Contract Research Organisations, Research Institutes, Other), by Function (Target Data, Sequencing & Target Data Analysis, Docking, Molecular Modelling, High Throughput Screening (HTS), Other), by Technique (Computer-Assisted Synthesis Design (CASD), Structure Representation, Chemmetrics, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1 Report Overview
1.1 Introduction to Drug Discovery Informatics Market
1.2 What are the Objectives of this Report?
1.3 What is the Scope of the Report?
1.4 Drug Discovery Informatics Market Definition
1.5 Why You Should Read This Report
1.6 What This Report Delivers
1.7 Key Questions Answered by This Analytical Report Include:
1.8 Who is This Report for?
1.9 Research Methodology
1.10 Frequently Asked Questions (FAQs)
1.11 Associated Visiongain Reports
1.12 About Visiongain
2 Executive Summary
3 Drug Discovery Informatics Industry Structure
3.1 Drug Discovery
3.2 Drug Development
4 Global Market Dynamics
4.1 Current Trends in the Global Market
4.2 Market Driving Factors
4.3 Market Restraining Factors
4.4 Opportunities in the Global Market
4.5 Challenges in the Global Market
4.6 Swot Analysis for Global Market
4.7 PEST Analysis for Global Market
4.8 Porter’s Five Forces
5 Global Drug Discovery Informatics Market Analysis
5.1 Global Market Outlook
5.2 Global Market Size Estimation and Forecast
5.3 Global Market Size Estimation and Forecast by Region
5.4 Global Market Size Estimation and Forecast by Type
5.5 Global Market Size Estimation and Forecast by Phase
5.6 Global Market Size Estimation and Forecast by End-User
5.7 Global Market Size Estimation and Forecast by Functions
5.8 Global Market Size Estimation and Forecast by Technique
6 North America Drug Discovery Informatics Market Analysis
6.1 North America Market Outlook
6.2 North America Market Size Estimation and Forecast
6.3 North America Market Size Estimation and Forecast by Country
6.4 North America Market Size Estimation and Forecast by Type
6.5 North America Market Size Estimation and Forecast by Phase
6.6 North America Market Size Estimation and Forecast by End-User
6.7 North America Market Size Estimation and Forecast by Functions
6.8 North America Market Size Estimation and Forecast by Technique
6.9 US Drug Discovery Informatics Market Analysis
6.10 Canada Drug Discovery Informatics Market Analysis
6.11 Mexico Drug Discovery Informatics Market Analysis
7 Europe Drug Discovery Informatics Market Analysis
7.1 Europe Market Outlook
7.2 Europe Market Size Estimation and Forecast
7.3 Europe Market Size Estimation and Forecast by Country
7.4 Europe Market Size Estimation and Forecast by Type
7.5 Europe Market Size Estimation and Forecast by Phase
7.6 Europe Market Size Estimation and Forecast by End-User
7.7 Europe Market Size Estimation and Forecast by Functions
7.8 Europe Market Size Estimation and Forecast by Technique
7.9 Germany Drug Discovery Informatics Market Analysis
7.10 UK Drug Discovery Informatics Market Analysis
7.11 France Drug Discovery Informatics Market Analysis
7.12 Italy Drug Discovery Informatics Market Analysis
7.13 Spain Drug Discovery Informatics Market Analysis
7.14 Rest of Europe Drug Discovery Informatics Market Analysis
8 Asia-Pacific Drug Discovery Informatics Market Analysis
8.1 Asia-Pacific Market Outlook
8.2 Asia-Pacific Market Size Estimation and Forecast
8.3 Asia-Pacific Market Size Estimation and Forecast by Country
8.4 Asia-Pacific Market Size Estimation and Forecast by Type
8.5 Asia-Pacific Market Size Estimation and Forecast by Phase
8.6 Asia-Pacific Market Size Estimation and Forecast by End-User
8.7 Asia-Pacific Market Size Estimation and Forecast by Functions
8.8 Asia-Pacific Market Size Estimation and Forecast by Technique
8.9 China Drug Discovery Informatics Market Analysis
8.10 India Drug Discovery Informatics Market Analysis
8.11 Japan Drug Discovery Informatics Market Analysis
8.12 South Korea Drug Discovery Informatics Market Analysis
8.13 Australia Drug Discovery Informatics Market Analysis
8.14 Rest of Asia-Pacific Drug Discovery Informatics Market Analysis
9 LAMEA Drug Discovery Informatics Market Analysis
9.1 LAMEA Market Outlook
9.2 LAMEA Market Size Estimation and Forecast
9.3 LAMEA Market Size Estimation and Forecast by Country
9.4 LAMEA Market Size Estimation and Forecast by Type
9.5 LAMEA Market Size Estimation and Forecast by Phase
9.6 LAMEA Market Size Estimation and Forecast by End-User
9.7 LAMEA Market Size Estimation and Forecast by Functions
9.8 LAMEA Market Size Estimation and Forecast by Technique
9.9 Brazil Drug Discovery Informatics Market Analysis
9.10 South Africa Drug Discovery Informatics Market Analysis
9.11 Saudi Arabia Drug Discovery Informatics Market Analysis
9.12 Turkey Drug Discovery Informatics Market Analysis
9.13 UAE Drug Discovery Informatics Market Analysis
9.14 Rest of LAMEA Drug Discovery Informatics Market Analysis
9.15 Colombia
10 Leading Company Profiles
10.1 Growth Strategy Allows Companies to Expand Their Business
10.2 Jubilant Life Sciences
10.3 Charles River Laboratories International
10.4 International Business Machines Corporation
10.5 Clarivate Analytics
10.6 Accenture
10.7 Cognizant Technology Solutions Corporation
10.8 Thermo Fisher Scientific
10.9 Infosys Limited
10.10 GVK Biosciences
10.11 IO Informatics
10.12 OpenEye Scientific Software Inc.
10.13 Dassault Systèmes SE
10.14 Collaborative Drug Discovery
10.15 Schrödinger, Inc
10.16 PerkinElmer Inc
11 Conclusion and Recommendations
12 Glossary Terms
List of Tables
Table 1. Global Drug Discovery Informatics Market Snapshot, 2021 & 2031 (US$million, CAGR %)
Table 2. Drug Discovery Swot Analysis
Table 3. Global Drug Discovery Informatics Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 4. Global Drug Discovery Informatics Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 5. Global Drug Discovery Informatics Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 6. Global Drug Discovery Informatics Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 7. Global Drug Discovery Informatics Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 8. Global Drug Discovery Informatics Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 9. Global Drug Discovery Informatics Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 10. Global Drug Discovery Informatics Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 11. Global Drug Discovery Informatics Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 12. Global Drug Discovery Informatics Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L– Shaped Recovery)
Table 13. Global Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 14. Global Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 15. Global Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W– Shaped Recovery)
Table 16. Global Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 17. Global Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 18. Global Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 19. Global Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 20. Global Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 21. Global Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 22. Global Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L– Shaped Recovery)
Table 23. Global Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 24. Global Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 25. Global Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 26. Global Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 27. Global Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 28. Global Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 29. Global Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 30. Global Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W– Shaped Recovery)
Table 31. Global Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 32. Global Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 33. Global Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 34. Global Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 35. Global Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 36. Global Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 37. Global Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 38. North America Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 39. North America Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 40. North America Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 41. North America Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 42. North America Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 43. North America Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 44. North America Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 45. North America Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 46. North America Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 47. North America Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 48. North America Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 49. North America Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 50. North America Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 51. North America Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 52. North America Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 53. North America Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 54. North America Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 55. North America Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 56. North America Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 57. North America Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 58. North America Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 59. North America Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 60. North America Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 61. North America Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 62. North America Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 63. North America Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 64. North America Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 65. North America Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 66. North America Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 67. North America Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 68. North America Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 69. North America Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 70. North America Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 71. North America Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 72. North America Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 73. US Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 74. US Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 75. US Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 76. US Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 77. US Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 78. Canada Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 79. Canada Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 80. Canada Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 81. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 82. Canada Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 83. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 84. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 85. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 86. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 87. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 88. Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 89. Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 90. Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 91. Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 92. Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 93. Europe Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 94. Europe Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 95. Europe Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 96. Europe Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 97. Europe Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 98. Europe Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 99. Europe Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 100. Europe Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 101. Europe Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 102. Europe Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 103. Europe Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 104. Europe Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 105. Europe Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 106. Europe Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 107. Europe Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 108. Europe Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 109. Europe Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 110. Europe Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 111. Europe Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 112. Europe Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 113. Europe Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 114. Europe Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 115. Europe Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 116. Europe Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 117. Europe Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 118. Europe Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 119. Europe Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 120. Europe Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 121. Europe Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 122. Europe Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 123. Germany Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 124. Germany Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 125. Germany Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 126. Germany Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 127. Germany Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 128. UK Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 129. UK Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 130. UK Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 131. UK Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 132. UK Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 133. France Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 134. France Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 135. France Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 136. France Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 137. France Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 138. Italy Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 139. Italy Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 140. Italy Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 141. Italy Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 142. Italy Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 143. Spain Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 144. Spain Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 145. Spain Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 146. Spain Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 147. Spain Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 148. Rest of Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 149. Rest of Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 150. Rest of Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 151. Rest of Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 152. Rest of Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 153. Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 154. Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 155. Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 156. Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 157. Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 158. Asia-Pacific Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 159. Asia-Pacific Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 160. Asia-Pacific Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 161. Asia-Pacific Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 162. Asia-Pacific Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 163. Asia-Pacific Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 164. Asia-Pacific Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 165. Asia-Pacific Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 166. Asia-Pacific Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 167. Asia-Pacific Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 168. Asia-Pacific Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 169. Asia-Pacific Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 170. Asia-Pacific Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 171. Asia-Pacific Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 172. Asia-Pacific Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 173. Asia-Pacific Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 174. Asia-Pacific Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 175. Asia-Pacific Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 176. Asia-Pacific Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 177. Asia-Pacific Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 178. Asia-Pacific Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 179. Asia-Pacific Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 180. Asia-Pacific Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 181. Asia-Pacific Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 182. Asia-Pacific Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 183. Asia-Pacific Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 184. Asia-Pacific Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 185. Asia-Pacific Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 186. Asia-Pacific Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 187. Asia-Pacific Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 188. China Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 189. China Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 190. China Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 191. China Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 192. China Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 193. India Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 194. India Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 195. India Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 196. India Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U– Shaped Recovery)
Table 197. India Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L– Shaped Recovery)
Table 198. Japan Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 199. Japan Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 200. Japan Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 201. Japan Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 202. Japan Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 203. South Korea Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 204. South Korea Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 205. South Korea Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 206. South Korea Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 207. South Korea Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 208. Australia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 209. Australia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 210. Australia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 211. Australia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 212. Australia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 213. Rest of Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 214. Rest of Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 215. Rest of Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 216. Rest of Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 217. Rest of Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 218. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 219. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 220. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 221. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 222. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L– Shaped Recovery)
Table 223. LAMEA Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 224. LAMEA Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 225. LAMEA Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 226. LAMEA Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 227. LAMEA Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 228. LAMEA Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 229. LAMEA Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 230. LAMEA Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 231. LAMEA Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 232. LAMEA Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 233. LAMEA Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 234. LAMEA Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 235. LAMEA Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 236. LAMEA Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 237. LAMEA Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 238. LAMEA Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 239. LAMEA Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 240. LAMEA Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 241. LAMEA Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 242. LAMEA Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 243. LAMEA Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 244. LAMEA Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 245. LAMEA Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W– Shaped Recovery)
Table 246. LAMEA Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 247. LAMEA Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 248. LAMEA Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 249. LAMEA Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 250. LAMEA Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 251. LAMEA Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 252. LAMEA Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 253. Brazil Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 254. Brazil Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 255. Brazil Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 256. Brazil Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 257. Brazil Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 258. South Africa Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 259. South Africa Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 260. South Africa Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 261. South Africa Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 262. South Africa Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 263. Saudi Arabia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 264. Saudi Arabia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 265. Saudi Arabia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 266. Saudi Arabia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 267. Saudi Arabia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 268. Turkey Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 269. Turkey Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 270. Turkey Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 271. Turkey Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 272. Turkey Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 273. UAE Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 274. UAE Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 275. UAE Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 276. UAE Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 277. UAE Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 278. Rest of LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 279. Rest of LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 280. Rest of LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 281. Rest of LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 282. Rest of LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 287. Jubilant Life Sciences Limited: Company Information
Table 288. Jubilant Life Sciences Limited: Company Product and Service Benchmarking
Table 289. Jubilant Life Sciences Limited: Company Recent Developments till Oct,2021
Table 290. Charles River Laboratories International, Inc.: Company Information
Table 291. Charles River Laboratories International, Inc.: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 292. Charles River Laboratories International, Inc.: Company Product and Service Benchmarking
Table 293. International Business Machines Corporation: Company Information
Table 294. International Business Machines Corporation: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 295. International Business Machines Corporation: Company Product and Service Benchmarking
Table 296. International Business Machines Corporation: Company Recent Developments till Oct,2021
Table 297. Clarivate Analytics Plc: Company Information
Table 298. Clarivate Analytics Plc: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 299. Clarivate Analytics Plc: Company Product and Service Benchmarking
Table 300. Clarivate Analytics Plc: Company Recent Developments till Oct,2021
Table 301. Accenture plc: Company Information
Table 302. Accenture plc: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 303. Accenture plc: Company Product and Service Benchmarking
Table 304. Accenture plc: Company Recent Developments till Oct,2021
Table 305. Cognizant Technology Solutions Corporation: Company Information
Table 306. Cognizant Technology Solutions Corporation: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 307. Cognizant Technology Solutions Corporation: Company Product and Service Benchmarking
Table 308. Cognizant Technology Solutions Corporation: Company Recent Developments till Oct,2021
Table 309. Thermo Fisher Scientific Inc: Company Information
Table 310. Thermo Fisher Scientific Inc: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 311. Thermo Fisher Scientific Inc: Company Product and Service Benchmarking
Table 312. Thermo Fisher Scientific Inc: Company Recent Developments till Oct,2021
Table 313. Infosys Limited: Company Information
Table 314. Infosys Limited: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 315. Infosys Limited: Company Product and Service Benchmarking
Table 316. Infosys Limited: Company Recent Developments till Oct,2021
Table 317. GVK Bioscinces: Company Information
Table 318. GVK Bioscinces: Company Product and Service Benchmarking
Table 319. GVK Bioscinces: Company Recent Developments till Oct,2021
Table 320. IO Informatics: Company Information
Table 321. IO Informatics: Company Product and Service Benchmarking
Table 322. IO Informatics: Company Recent Developments till Oct,2021
Table 323. OpenEye Scientific Software Inc.: Company Information
Table 324. OpenEye Scientific Software Inc: Company Product and Service Benchmarking
Table 325. OpenEye Scientific Software Inc.: Company Recent Developments till Oct,2021
Table 326. Dassault Systemes SE: Company Information
Table 327. Dassault Systemes SE: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 328. Dassault Systemes SE: Company Product and Service Benchmarking
Table 329. Dassault Systemes SE: Company Recent Developments till Oct,2021
Table 330. Collaborative Drug Discovery: Company Information
Table 331. Collaborative Drug Discovery: Company Product and Service Benchmarking
Table 332. Collaborative Drug Discovery: Company Recent Developments till Oct,2021
Table 333. Schrodinger, Inc: Company Information
Table 334. Schrodinger, Inc: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 335. Schrodinger, Inc: Company Product and Service Benchmarking
Table 336. Schrodinger, Inc: Company Recent Developments till Oct,2021
Table 337. PerkinElmer Inc: Company Information
Table 338. PerkinElmer Inc: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 339. PerkinElmer Inc: Company Product and Service Benchmarking
Table 340. PerkinElmer Inc: Company Recent Developments till Oct,2021
List of Figures
Figure 1. Global Drug Discovery Informatics Market Segmentation
Figure 2. Current Trends in the Global Market
Figure 3. Driving Factors in the Global Market
Figure 4. Market Restraining Factors in the Global Market
Figure 5. Opportunities in the Global Market
Figure 6. AI Intelligence in Drug Discovery and Development
Figure 7. Challenges in the Global Market
Figure 9. Global Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 10. Global Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 11. Global Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 12. Global Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 13. Global Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 14. Global Drug Discovery Informatics Market by Region, 2021-2031 (USD Mn, AGR (%))
Figure 15. Global Drug Discovery Informatics Market by Region, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 16. Global Drug Discovery Informatics Market by Region, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 17. Global Drug Discovery Informatics Market by Region, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 18. Global Drug Discovery Informatics Market by Region, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 19. Drug Discovery
Figure 20. Global Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%))
Figure 21. Global Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 22. Global Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 23. Global Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 24. Global Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 25. Global Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%))
Figure 26. Global Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 27. Global Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 28. Global Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 29. Global Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 30. Global Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%))
Figure 31. Global Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 32. Global Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 33. Global Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 34. Global Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 35. Sequencing and Target Data Analysis
Figure 36. Global Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%))
Figure 37. Global Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 38. Global Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 39. Global Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 40. Global Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 41. Structure Representation
Figure 42. Global Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%))
Figure 43. Global Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 44. Global Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 45. Global Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 46. Global Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 47. North America Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 48. North America Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 49. North America Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 50. North America Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 51. North America Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 52. North America Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%))
Figure 53. North America Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 54. North America Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 55. North America Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 56. North America Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 57. North America Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%))
Figure 58. North America Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 59. North America Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 60. North America Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 61. North America Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 62. North America Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%))
Figure 63. North America Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 64. North America Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 65. North America Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 66. North America Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 67. North America Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%))
Figure 68. North America Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 69. North America Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 70. North America Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 71. North America Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 72. North America Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%))
Figure 73. North America Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 74. North America Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 75. North America Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 76. North America Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 77. North America Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%))
Figure 78. North America Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 79. North America Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 80. North America Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 81. North America Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 82. US Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 83. US Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 84. US Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 85. US Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 86. US Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 87. Canada Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 88. Canada Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 89. Canada Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 90. Canada Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 91. Canada Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 92. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 93. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 94. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 95. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 96. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 97. Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 98. Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 99. Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 100. Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 101. Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 102. Europe Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%))
Figure 103. Europe Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 104. Europe Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 105. Europe Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 106. Europe Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 107. Europe Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%))
Figure 108. Europe Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 109. Europe Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 110. Europe Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 111. Europe Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 112. Europe Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%))
Figure 113. Europe Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 114. Europe Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 115. Europe Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 116. Europe Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 117. Europe Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%))
Figure 118. Europe Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 119. Europe Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 120. Europe Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 121. Europe Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 122. Europe Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%))
Figure 123. Europe Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 124. Europe Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 125. Europe Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 126. Europe Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 127. Europe Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%))
Figure 128. Europe Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 129. Europe Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 130. Europe Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 131. Europe Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 132. Germany Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 133. Germany Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 134. Germany Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 135. Germany Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 136. Germany Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 137. UK Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 138. UK Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 139. UK Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 140. UK Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 141. UK Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 142. France Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 143. France Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 144. France Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 145. France Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 146. France Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 147. Italy Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 148. Italy Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 149. Italy Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 150. Italy Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 151. Italy Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 152. Spain Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 153. Spain Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 154. Spain Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 155. Spain Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 156. Spain Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 157. Rest of Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 158. Rest of Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 159. Rest of Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 160. Rest of Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 161. Rest of Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 162. Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 163. Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 164. Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 165. Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 166. Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 167. Asia-Pacific Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%))
Figure 168. Asia-Pacific Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 169. Asia-Pacific Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 170. Asia-Pacific Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 171. Asia-Pacific Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 172. Asia-Pacific Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%))
Figure 173. Asia-Pacific Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 174. Asia-Pacific Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 175. Asia-Pacific Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 176. Asia-Pacific Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 177. Asia-Pacific Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%))
Figure 178. Asia-Pacific Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 179. Asia-Pacific Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 180. Asia-Pacific Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 181. Asia-Pacific Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 182. Asia-Pacific Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%))
Figure 183. Asia-Pacific Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 184. Asia-Pacific Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 185. Asia-Pacific Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 186. Asia-Pacific Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 187. Asia-Pacific Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%))
Figure 188. Asia-Pacific Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 189. Asia-Pacific Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 190. Asia-Pacific Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 191. Asia-Pacific Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 192. Asia-Pacific Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%))
Figure 193. Asia-Pacific Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 194. Asia-Pacific Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 195. Asia-Pacific Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 196. Asia-Pacific Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 197. China Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 198. China Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 199. China Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 200. China Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 201. China Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 202. India Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 203. India Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 204. India Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 205. India Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 206. India Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 207. Japan Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 208. Japan Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 209. Japan Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 210. Japan Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 211. Japan Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 212. South Korea Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 213. South Korea Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 214. South Korea Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 215. South Korea Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 216. South Korea Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 217. Australia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 218. Australia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 219. Australia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 220. Australia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 221. Australia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 222. Rest of Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 223. Rest of Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 224. Rest of Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 225. Rest of Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 226. Rest of Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 227. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 228. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 229. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 230. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 231. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 232. LAMEA Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%))
Figure 233. LAMEA Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 234. LAMEA Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 235. LAMEA Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 236. LAMEA Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 237. LAMEA Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%))
Figure 238. LAMEA Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 239. LAMEA Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 240. LAMEA Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 241. LAMEA Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 242. LAMEA Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%))
Figure 243. LAMEA Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 244. LAMEA Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 245. LAMEA Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 246. LAMEA Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 247. LAMEA Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%))
Figure 248. LAMEA Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 249. LAMEA Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 250. LAMEA Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 251. LAMEA Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 252. LAMEA Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%))
Figure 253. LAMEA Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 254. LAMEA Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 255. LAMEA Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 256. LAMEA Drug Discovery Informatics Market by Functions, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 257. LAMEA Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%))
Figure 258. LAMEA Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 259. LAMEA Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 260. LAMEA Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 261. LAMEA Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 262. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 263. Brazil Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 264. Brazil Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 265. Brazil Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 266. Brazil Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 267. South Africa Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 268. South Africa Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 269. South Africa Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 270. South Africa Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 271. South Africa Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 272. Saudi Arabia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 273. Saudi Arabia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 274. Saudi Arabia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 275. Saudi Arabia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 276. Saudi Arabia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 277. Turkey Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 278. Turkey Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 279. Turkey Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 280. Turkey Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 281. Turkey Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 282. UAE Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 283. UAE Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 284. UAE Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 285. UAE Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 286. UAE Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 287. Rest of LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 288. Rest of LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 289. Rest of LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 290. Rest of LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 291. Rest of LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 292. Charles River Laboratories International, Inc.: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 293. Charles River Laboratories International, Inc.: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 294. Charles River Laboratories International, Inc.: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 295. Charles River Laboratories International, Inc.: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 296. International Business Machines Corporation: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 297. International Business Machines Corporation: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 298. International Business Machines Corporation: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 299. International Business Machines Corporation: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 300. Clarivate Analytics Plc: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 301. Clarivate Analytics Plc: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 302. Clarivate Analytics Plc: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 303. Clarivate Analytics Plc: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 304. Accenture plc: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 305. Accenture plc: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 306. Accenture plc: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 307. Accenture plc: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 308. Cognizant Technology Solutions Corporation: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 309. Cognizant Technology Solutions Corporation: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 310. Cognizant Technology Solutions Corporation: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 311. Cognizant Technology Solutions Corporation: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 312. Thermo Fisher Scientific Inc: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 313. Thermo Fisher Scientific Inc: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 314. Thermo Fisher Scientific Inc: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 315. Thermo Fisher Scientific Inc: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 316. Infosys Limited: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 317. Infosys Limited: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 318. Infosys Limited: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 319. Infosys Limited: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 320. Dassault Systemes SE: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 321. Dassault Systemes SE: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 322. Dassault Systemes SE: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 323. Dassault Systemes SE: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 324. Schrodinger, Inc: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 325. Schrodinger, Inc: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 326. Schrodinger, Inc: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 327. Schrodinger, Inc: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 328. PerkinElmer Inc: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 329. PerkinElmer Inc: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 330. PerkinElmer Inc: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 331. PerkinElmer Inc: Company EBITDA 2016-2020 (US$Mn, AGR %)
List of Companies Profiled in the report
Accenture
Charles River Laboratories International
Clarivate Analytics
Cognizant Technology Solutions Corporation
Collaborative Drug Discovery
Dassault Systèmes SE
GVK Biosciences
Infosys Limited
International Business Machines Corporation
IO Informatics
Jubilant Life Sciences
OpenEye Scientific Software Inc.
PerkinElmer Inc
Schrödinger, Inc
Thermo Fisher Scientific
List of Other Companies Mentioned in the report
100,000 Genomes Project
3rd Millennium
Affymetrix
Agilent Technologies
Alphabet
Amazon
Applied Biosystems
AstraZeneca
AstridBio
Baylor College of Medicine
BioBam
BIOBASE
Biomatters
BioNano Genomics
BIOVIA (formerly Accelrys)
BlueGnome
Burning Rock
Canada Foundation for Innovation
Cancer Moonshot Task Force
Centre for Genomics Research [HLI]
CLC Bio
Compugen
Dassault Systèmes
DNAnexus
DNASTAR
DOE (Department of Energy) [US]
FEI Company
Finnish Institute for Molecular Medicine
Garvan Institute of Medical Research
GDC (Genomic Data Commons)
Geisinger Health Systems
Genentech (subsidiary of Roche)
Genome.One (subsidiary of Garvan Institute of Medical Research)
Genomics England
Genomics plc
Geospiza
GIS (Genome Institute of Singapore)
Google
Harvard School of Medicine
Health Education England
HGP (Human Genome Project)
HGSC (Human Genome Sequencing Center) [Baylor College of Medicine]
HLI (Human Longevity Inc)
Illumina
Ingenuity Systems
Integromics (subsidiary of PerkinElmer Informatics)
Invitrogen Corporation
LabCorp
Life Technologies (now renamed Thermo Fisher Scientific)
Memorial Sloan Kettering Cancer Center
MyCode Community Health Initiative [Geisinger Health Systems]
NCI (National Cancer Institute) [US]
NHS (National Health Service) [UK]
NIH (National Institute for Health Research) [UK]
Novogene
Ocimum Biosolutions
PerkinElmer
PerkinElmer Informatics (formerly CambridgeSoft Corporation, now subsidiary of PerkinElmer)
POLARIS (Personalised OMIC Lattice for Advanced Research and Improving Stratification)
QIAGEN
Regeneron
Regeneron Genetics Center
Roche
Sanger Centre
Saudi Genome Project
SCGPM (Stanford Center for Genomics and Personalised Medicine)
Solexa
Strand Lifesciences (subsidiary of Syngene International)
Syngene International
Thermo Fisher Scientific
University of California
University of Toronto
US National Human Genome Research Institute
VA (Department of Veterans Affairs) [US]
Verily Life Sciences (subsidiary of Alphabet)
Virginia Commonwealth University
Wellcome Trust Sanger Institute
WuXi NextCODE Genomics (subsidiary of WuXi PharmaTech)
WuXi PharmaTech
List of Associations Mentioned in the Report
American Association for Clinical Chemistry
American Society for Clinical Pathology
Australian Bureau of Statistics
Centers for Medicare & Medicaid Services
College of American Pathologists
Food and Drug Administration
Health Care Development Services, Inc.
National Accrediting Agency for Clinical Laboratory Sciences
National Center for Biotechnology Information
Office for National Statistics
U.S. Census Bureau
U.S. Department of Commerce
US Bureau of Labor Statistics
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
